Medtronic, Inc. (MDT) PT Lowered to $92 at BMO Capital on 1Q18 Report; 'Tricky Quarter, Tricky Guidance'
Tweet Send to a Friend
BMO Capital lowered its price target on Medtronic, Inc. (NYSE: MDT) to $92.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
